Characteristics of recurrence and surveillance tools after curative resection for colorectal cancer: A multicenter study

Surgery

Volumn 141, Issue 1, 2007, Pages 67-75

  Kobayashi, Hirotoshi ^a   Mochizuki, Hidetaka ^a   Sugihara, Kenichi ^b   Morita, Takayuki ^c   Kotake, Kenjiro ^d   Teramoto, Tatsuo ^e   Kameoka, Shingo ^f   Saito, Yukio ^g   Takahashi, Keiichi ^h   Hase, Kazuo ⁱ   Oya, Masatoshi ^j   Maeda, Koutarou ^k   Hirai, Takashi ^l   Kameyama, Masao ^m   Shirouzu, Kazuo ⁿ   Muto, Tetsuichiro ^j  

^a the Japanese Society for Cancer of the Colon and Rectum   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c HIROSAKI UNIVERSITY   (Japan)

^d TOCHIGI CANCER CENTER   (Japan)

^e TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^g NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^h TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

ⁱ Self Defense Forces Central Hospital   (Japan)

^j CANCER INSTITUTE HOSPITAL   (Japan)

^k FUJITA HEALTH UNIVERSITY   (Japan)

^l AICHI CANCER CENTER HOSPITAL   (Japan)

^m OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

ⁿ KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DOXIFLURIDINE; FLUOROURACIL; FOLINIC ACID; TEGAFUR;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CLINICAL TRIAL; COLON RESECTION; COLORECTAL CANCER; FEMALE; HUMAN; LIVER METASTASIS; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOMES RESEARCH; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THORAX RADIOGRAPHY; TREATMENT OUTCOME;

AGED; COLORECTAL NEOPLASMS; FEMALE; HUMANS; JAPAN; LIVER NEOPLASMS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS;

EID: 33845509483     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2006.07.020     Document Type: Article

References (20)

1. Jemal A., Tiwari R.C., Murray T., Ghafoor A., Samuels A., Ward E., et al. Cancer statistics, 2004. CA Cancer J Clin 54 (2004) 8-29
2. Kotake K., Honjo S., Sugihara K., Kato T., Kodaira S., Takahashi T., et al. Changes in colorectal cancer during a 20-year period: an extended report from the multi-institutional registry of large bowel cancer, Japan. Dis Colon Rectum 46 10 Suppl (2003) 32-43
3. O'Connell J.B., Maggard M.A., and Ko C.Y. Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst 96 (2004) 1420-1425
4. Andre T., Bensmaine M.A., Louvet C., Francois E., Lucas V., Desseigne F., et al. Multicenter phase II study of bimonthly high-dose leucovorin, fluorouracil infusion, and oxaliplatin for metastatic colorectal cancer resistant to the same leucovorin and fluorouracil regimen. J Clin Oncol 17 (1999) 3560-3568
5. de Gramont A., Figer A., Seymour M., Homerin M., Hmissi A., Cassidy J., et al. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 18 (2000) 2938-2947
6. Saltz L.B., Cox J.V., Blanke C., Rosen L.S., Fehrenbacher L., Moore M.J., et al., Irinotecan Study Group. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. N Engl J Med 343 (2000) 905-914
7. Douillard J.Y., Cunningham D., Roth A.D., Navarro M., James R.D., Karasek P., et al. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet 355 (2000) 1041-1047
8. Ohlsson B., Breland U., Ekberg H., Graffner H., and Tranberg K.G. Follow-up after curative surgery for colorectal carcinoma. Randomized comparison with no follow-up. Dis Colon Rectum 38 (1995) 619-626
9. Makela J.T., Laitinen S.O., and Kairaluoma M.I. Five-year follow-up after radical surgery for colorectal cancer. Results of a prospective randomized trial. Arch Surg 130 (1995) 1062-1067
10. Kjeldsen B.J., Kronborg O., Fenger C., and Jorgensen O.D. A prospective randomized study of follow-up after radical surgery for colorectal cancer. Br J Surg 84 (1997) 666-669
11. Schoemaker D., Black R., Giles L., and Toouli J. Yearly colonoscopy, liver CT, and chest radiography do not influence 5-year survival of colorectal cancer patients. Gastroenterology 114 (1998) 7-14
12. Pietra N., Sarli L., Costi R., Ouchemi C., Grattarola M., and Peracchia A. Role of follow-up in management of local recurrences of colorectal cancer: a prospective, randomized study. Dis Colon Rectum 41 (1998) 1127-1133
13. Secco G.B., Fardelli R., Gianquinto D., Bonfante P., Baldi E., Ravera G., et al. Efficacy and cost of risk-adapted follow-up in patients after colorectal cancer surgery: a prospective, randomized and controlled trial. Eur J Surg Oncol 28 (2002) 418-423
14. Renehan A.G., Egger M., Saunders M.P., and O'Dwyer S.T. Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials. BMJ 324 (2002) 813
15. Jeffery GM, Hickey BE, Hider P. Follow-up strategies for patients treated for non-metastatic colorectal cancer. Cochrane Database Syst Rev 2002(1):CD002200. Available from http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11899629.
16. Figueredo A., Rumble R.B., Maroun J., Earle C.C., Cummings B., McLeod R., et al. Follow-up of patients with curatively resected colorectal cancer: a practice guideline. BMC Cancer 3 (2003) 26
17. Guillem J.G., Chessin D.B., Cohen A.M., Shia J., Mazumdar M., Enker W., et al. Long-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancer. Ann Surg 241 (2005) 829-836 discussion 836.
18. Weiss L., Grundmann E., Torhorst J., Hartveit F., Moberg I., Eder M., et al. Haematogenous metastatic patterns in colonic carcinoma: an analysis of 1541 necropsies. J Pathol 150 (1986) 195-203
19. Renehan A.G., O'Dwyer S.T., and Whynes D.K. Cost effectiveness analysis of intensive versus conventional follow up after curative resection for colorectal cancer. BMJ 328 (2004) 81
20. Grossmann E.M., Johnson F.E., Virgo K.S., Longo W.E., and Fossati R. Follow-up of colorectal cancer patients after resection with curative intent-the GILDA trial. Surg Oncol 13 (2004) 119-124